Center-Authored Papers

Filters: Author is Martins, Renato  [Clear All Filters]
A B C D E F G H I J K L M N O P Q R S T U V W X Y Z 
A
Araki D, Redman MW, Martins R, Eaton K, Baik C, Chow L, Goulart B, Lee S, Santana-Davila R, Liao J et al..  2016.  Concurrent cetuximab and postoperative radiation in resected high-risk squamous cell carcinomas of the head and neck: A single-institution experience.. Head & neck. Abstract
Augert A, Eastwood E, Ibrahim AH, Wu N, Grunblatt E, Basom R, Liggitt D, Eaton KD, Martins R, Poirier JT et al..  2019.  Targeting NOTCH activation in small cell lung cancer through LSD1 inhibition.. Science signaling. 12(567) Abstract
B
Brahmer JR, Tykodi SS, Chow LQM, Hwu W-J, Topalian SL, Hwu P, Drake CG, Camacho LH, Kauh J, Odunsi K et al..  2012.  Safety and activity of anti-PD-L1 antibody in patients with advanced cancer.. The New England journal of medicine. 366(26):2455-65. Abstract
E
Ettinger DS, Akerley W, Borghaei H, Chang AC, Cheney RT, Chirieac LR, D'Amico TA, Demmy TL, Ganti AKP, Govindan R et al..  2012.  Non-small cell lung cancer.. Journal of the National Comprehensive Cancer Network : JNCCN. 10(10):1236-71. Abstract
Ettinger DS, Akerley W, Borghaei H, Chang A, Cheney RT, Chirieac LR, D'Amico TA, Demmy TL, Ganti AKP, Govindan R et al..  2012.  Malignant pleural mesothelioma.. Journal of the National Comprehensive Cancer Network : JNCCN. 10(1):26-41.
Ettinger DS, Wood DE, Aisner DL, Akerley W, Bauman J, Chirieac LR, D'Amico TA, Decamp MM, Dilling TJ, Dobelbower M et al..  2017.  Non-Small Cell Lung Cancer, Version 5.2017, NCCN Clinical Practice Guidelines in Oncology.. Journal of the National Comprehensive Cancer Network : JNCCN. 15(4):504-535. Abstract
Ettinger DS, Wood DE, Akerley W, Bazhenova LA, Borghaei H, Camidge DR, Cheney RT, Chirieac LR, D'Amico TA, Dilling T et al..  2016.  NCCN Guidelines Insights: Malignant Pleural Mesothelioma, Version 3.2016.. Journal of the National Comprehensive Cancer Network : JNCCN. 14(7):825-36. Abstract
Ettinger DS, Akerley W, Borghaei H, Chang AC, Cheney RT, Chirieac LR, D'Amico TA, Demmy TL, Govindan R, Grannis FW et al..  2013.  Non-Small Cell Lung Cancer, Version 2.2013.. Journal of the National Comprehensive Cancer Network : JNCCN. 11(6):645-653. Abstract
Ettinger DS, Wood DE, Akerley W, Bazhenova LA, Borghaei H, Camidge DR, Cheney RT, Chirieac LR, D'Amico TA, Demmy TL et al..  2014.  Non-small cell lung cancer, version 1.2015.. Journal of the National Comprehensive Cancer Network : JNCCN. 12(12):1738-61. Abstract
Ettinger DS, Riely GJ, Akerley W, Borghaei H, Chang AC, Cheney RT, Chirieac LR, D'Amico TA, Demmy TL, Govindan R et al..  2013.  Thymomas and thymic carcinomas: Clinical Practice Guidelines in Oncology.. Journal of the National Comprehensive Cancer Network : JNCCN. 11(5):562-76. Abstract
Ettinger DS, Wood DE, Akerley W, Bazhenova LA, Borghaei H, Camidge DR, Cheney RT, Chirieac LR, D'Amico TA, Demmy TL et al..  2015.  Non-small cell lung cancer, version 6.2015.. Journal of the National Comprehensive Cancer Network : JNCCN. 13(5):515-24. Abstract
F
Ferreira BP, Redman M, Baker KK, Martins R, Eaton KD, Chow LQM, Baik CS, Goulart B, Lee SM, Santana-Davila R et al..  2016.  Predictors of outcome with cetuximab and paclitaxel for head and neck squamous cell carcinoma.. The Laryngoscope. Abstract
J
Jänne PA, Ou S-HI, Kim D-W, Oxnard GR, Martins R, Kris MG, Dunphy F, Nishio M, O'Connell J, Paweletz C et al..  2014.  Dacomitinib as first-line treatment in patients with clinically or molecularly selected advanced non-small-cell lung cancer: a multicentre, open-label, phase 2 trial.. The Lancet. Oncology. 15(13):1433-41. Abstract
M
Mellati M, Eaton KD, Brooks-Worrell BM, Hagopian WA, Martins R, Palmer JP, Hirsch IB.  2015.  Anti-PD-1 and Anti-PDL-1 Monoclonal Antibodies Causing Type 1 Diabetes.. Diabetes care.
Méndez E, Rodriguez CP, Kao M, Raju SC, Diab A, Harbison RA, Konnick EQ, Mugundu G, Santana-Davila R, Martins R et al..  2018.  A Phase I Clinical Trial of AZD1775 in Combination With Neoadjuvant Weekly Docetaxel and Cisplatin Before Definitive Therapy in Head and Neck Squamous Cell Carcinoma.. Clinical cancer research : an official journal of the American Association for Cancer Research. 24(12):2740-2748. Abstract
O
Oh D, Goulart BHL, Martins R.  2014.  The Value of Pathology Review in Advanced Common Cancers. Journal of Investigative Medicine. 62:219-219. Abstract
P
Pfister DG, Ang K-K, Brizel DM, Burtness B, Cmelak AJ, Colevas DA, Dunphy F, Eisele DW, Gilbert J, Gillison ML et al..  2012.  Mucosal melanoma of the head and neck.. Journal of the National Comprehensive Cancer Network : JNCCN. 10(3):320-38.
Pritchard CC, Salipante SJ, Koehler K, Smith C, Scroggins S, Wood B, Wu D, Lee MK, Dintzis S, Adey A et al..  2014.  Validation and implementation of targeted capture and sequencing for the detection of actionable mutation, copy number variation, and gene rearrangement in clinical cancer specimens.. The Journal of molecular diagnostics : JMD. 16(1):56-67. Abstract
S
Santana-Davila R, Martins R.  2016.  Treatment of Stage IIIA Non-Small-Cell Lung Cancer: A Concise Review for the Practicing Oncologist.. Journal of oncology practice / American Society of Clinical Oncology. 12(7):601-6. Abstract
V
Veatch JR, Jesernig BL, Kargl J, Fitzgibbon M, Lee SM, Baik C, Martins R, Houghton MGA, Riddell SR.  2019.  Endogenous CD4 T Cells Recognize Neoantigens in Lung Cancer Patients, Including Recurrent Oncogenic and () Driver Mutations.. Cancer immunology research. 7(6):910-922. Abstract